Perimeter Medical Imaging Inc Announces 510(k) Clearance by FDA

Perimeter Medical Imaging, Inc. (“Perimeter Medical”) announced today that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the second generation of their platform imaging tool used in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization.

Read More
Dawna Panas
Perimeter Enters into Data Transfer Agreement with Columbia University

Perimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tumour margin assessment, today announced they have reached a data sharing agreement with Columbia University whereby the company and University will share Optical Coherence Tomography (OCT) image data to accelerate research efforts for high resolution tissue imaging.

Read More
kevin chia
FedDev Ontario Supports OTIS™

Perimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tumour margin assessment, today announced it is receiving up to $980,000 from the Government of Canada through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario).

Read More
kevin chia
Perimeter Medical Imaging Receives HTX Funding

Perimeter Medical Imaging Inc., a developer of real time imaging systems for in surgery tumour margin assessment, today announced financing support for the next phase of product and clinical development, provided by the Health Technology Commercialization Program through htx.ca - The Health Technology Exchange (HTX) and with the support of Princess Margaret Cancer Centre, a University Health Network hospital.

Read More
kevin chia